Komori
Medical Ikkou Group (3353) · RiskSlight decrease in equity interest, relationship continues

Risk Relating to Capital and Business Relationships with AEON CO.,LTD.

First written in FY2018. 3 of 7 entries say "Restated". Latest entry: FY2026.

7entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY20262018: 120182019: 120192020: 020202021: 120212022: 020222023: 020232024: 020242025: 220252026: 22026
Same theme, other companies
Risk of Changes in Personnel, Sales and Business Relationships with Major ShareholdersA theme 19 companies write about · 18 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2025: 2 of 13 companies on the "Worse" side.

6 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2026Slight decrease in equity interest, relationship continuesAnnual report

    「As of the end of February 2026, AEON CO.,LTD.'s ownership interest in the Company was 27.05% (1,020,000 shares), and the person responsible for Health & Wellness at AEON CO.,LTD. serves as a corporate auditor of the Company.」

    AEON CO.,LTD.'s ownership interest edged down from the previously reported 27.08% to 27.05%, while the capital and business relationship, including its holding of 1,020,000 shares, the appointment of its representative as a corporate auditor and store leases, continues.
  2. 2026-03-26RestatedGovernance

    「AEON CO.,LTD. is our largest shareholder, holding 27.12% of our voting rights, and is another related company. We have a capital alliance with AEON CO.,LTD. and belong to the corporate group comprising AEON CO.,LTD. and its group companies.」

    The disclosure continues to describe the capital alliance with AEON CO.,LTD., its status as another related company, its investment option in connection with capital increases, and interlocking directorships. Its voting-rights ownership ratio is 27.12%, a slight increase from the 27.08% stated in the most recent canonical disclosure. The disclosure also states that there are no management constraints and that independence is secured.
  3. FY2026-H1Increase in equity interestAnnual report

    「AEON CO.,LTD. 1,020,000 27.08」

    AEON CO.,LTD. held 1,020,000 shares, representing 27.08% of shares issued, excluding treasury shares. The ownership percentage increased from the previously reported 25.06%.
  4. FY2025RestatedAnnual report

    「As of the end of February 2025, AEON CO.,LTD. held a 25.06% interest in the Company, representing 1,020,000 shares, and an adviser to AEON CO.,LTD. served as a corporate auditor of the Company.」

    Continues to disclose AEON CO.,LTD.'s 25.06% equity interest, its adviser's appointment as a corporate auditor, the investment option in the event of a capital increase, and the store leasing relationship.
  5. FY2022-Q2Increase in equity interest and expansion of related partiesAnnual report

    「In June 2021, 株式会社ハピネスライフ一光, the core subsidiary of the healthcare business, conducted a third-party allotment of new shares to AEON CO.,LTD. and TOHO HOLDINGS CO.,LTD.」

    In addition to AEON CO.,LTD., TOHO HOLDINGS CO.,LTD. became an allottee in the third-party allotment, and the shareholder composition as of the end of August 2021 showed ownership ratios of 27.15% for AEON CO.,LTD. and 5.40% for TOHO HOLDINGS CO.,LTD.
  6. FY2019RestatedAnnual report

    「As of the end of February 2019, AEON CO.,LTD. held a 25.06% interest in the Company, representing 510,000 shares, and an adviser to AEON CO.,LTD. served as a corporate auditor of the Company.」

    Continues to disclose AEON CO.,LTD.'s 25.06% investment, its adviser's appointment as a corporate auditor, the investment option in the event of a capital increase, and the store leasing relationship.
  7. FY2018First statedAnnual report

    「As of the end of February 2018, AEON CO.,LTD. held a 25.06% interest in the Company, representing 510,000 shares, and an adviser to AEON CO.,LTD. served as a corporate auditor of the Company. In addition, if the Company conducts a capital increase, AEON CO.,LTD. has an option to make an investment that would ensure its ownership ratio does not fall below 25% of the total number of shares issued after the capital increase.」

    Discloses as significant matters relating to the relationship AEON CO.,LTD.'s 25.06% investment, its adviser's appointment as a corporate auditor, the investment option in the event of a capital increase, and the store leasing relationship.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet. It last moved in the Governance of 2026-03-26: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk Relating to Capital and Business Relationships with AEON CO.,LTD. | Medical Ikkou Group Co.,Ltd. (3353) | Komori